Evidence map›Paper›PMID 26095685›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Cartilage-Specific Near-Infrared Fluorophores for Biomedical Imaging.

Hoon Hyun, Eric A Owens, Hideyuki Wada, Andrew Levitz, GwangLi Park, Min Ho Park, John V Frangioni, Maged Henary, Hak Soo Choi

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Cationic Peptoids for Systemic In Vivo Cartilage-Targeting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Tissue-seeking dyes for in vivo applications.Smart molecules : open access · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. NIR fluorescence imaging and treatment for cancer immunotherapy.Journal for immunotherapy of cancer · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hoon HyunDivision of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, SL436A, Boston, MA 02215 (USA).
Eric A OwensDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303 (USA).
Hideyuki WadaDivision of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, SL436A, Boston, MA 02215 (USA).
Andrew LevitzDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303 (USA).
GwangLi ParkDivision of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, SL436A, Boston, MA 02215 (USA).
Min Ho ParkDivision of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, SL436A, Boston, MA 02215 (USA).
John V FrangioniDivision of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, SL436A, Boston, MA 02215 (USA).
Maged HenaryDepartment of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303 (USA). mhenary1@gsu.edu.
Hak Soo ChoiDivision of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, SL436A, Boston, MA 02215 (USA). hchoi@bidmc.harvard.edu.

Funding

(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and TreatmentR01CA185457 · NCI · CURADEL, LLC · PI FRANGIONI, JOHN V · 2014 to 2017
$3.9M
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided SurgerR01EB010022 · NIBIB · CURADEL, LLC · PI FRANGIONI, JOHN V · 2010 to 2013
$2.8M
Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared FluR01EB011523 · NIBIB · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHOI, HAK SOO · 2010 to 2013
$2.0M
NCI NIH HHS R01 CA185457NIBIB NIH HHS R01 EB010022NIBIB NIH HHS R01-EB-010022NIBIB NIH HHS R01 EB011523NIBIB NIH HHS R01-EB-011523
6 · The paper itself

Abstract

A novel class of near-infrared fluorescent contrast agents was developed. These agents target cartilage with high specificity and this property is inherent to the chemical structure of the fluorophore. After a single low-dose intravenous injection and a clearance time of approximately 4 h, these agents bind to all three major types of cartilage (hyaline, elastic, and fibrocartilage) and perform equally well across species. Analysis of the chemical structure similarities revealed a potential pharmacophore for cartilage targeting. Our results lay the foundation for future improvements in tissue engineering, joint surgery, and cartilage-specific drug development.

Indexed as

Optical ImagingAdministration, IntravenousAnimalsCartilageContrast MediaFluorescent DyesMaleMiceSpectroscopy, Near-InfraredContrast MediaFluorescent Dyescartilagefluorophoresimaging agentsNIR fluorescencetargeted dyes

Identifiers

PMID26095685
PMCPMC4504790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.